A critical discovery in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently disabled in various types of malignancies, https://freshbookmarking.com/story21948986/vhh-fragments-reactivate-p53-the-potential-hope-for-malignant-management